The comparator drug sourcing market is growing as pharmaceutical and biotechnology companies conduct more complex clinical trials across multiple countries. The market was valued at USD 24.17 billion in 2024 and is projected to reach USD 31.8 billion by 2032, growing at a CAGR of 3.49%. 1101 Comparator drugs are approved medicines used as reference treatments in clinical studies. They help...